Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean Sachdev

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Neuro-Oncology Practice|February 7, 2025
Clinical outcomes for pleomorphic xanthoastrocytoma patientsJared J Sullivan, James P Chandler, Maciej S Lesniak, et al.
Journal of Neuro-Oncology|November 12, 2020
Long-term outcomes of spinal ependymomas: an institutional experience of more than 60 casesRohan Savoor, Timothy L Sita, Nader S Dahdaleh, et al.
CNS Oncology|May 23, 2023
HER2+ esophageal carcinoma leptomeningeal metastases treated with intrathecal trastuzumab regimenScott A Wu, Dan Tong Jia, Margaret Schwartz, et al.
Journal of Neuro-Oncology|June 12, 2024
Long-term outcomes of central neurocytoma - an institutional experienceYufan Yang, Nitin Wadhwani, Aoi Shimomura, et al.
World Neurosurgery|June 20, 2022
Mean Brain Dose Remains Uninfluenced by the Lesion Number for Gamma Knife Stereotactic Radiosurgery for 10+ MetastasesTimothy L Sita, Mahesh Gopalakrishnan, Michael K Rooney, et al.
Journal of Neuro-Oncology|October 24, 2021
A multi-center prospective study of re-irradiation with bevacizumab and temozolomide in patients with bevacizumab refractory recurrent high-grade gliomasKaran S Dixit, Sean Sachdev, Christina Amidei, et al.
BMC Cancer|April 25, 2024
A qualitative evaluation of factors influencing Tumor Treating fields (TTFields) therapy decision making among brain tumor patients and physiciansPriya Kumthekar, Madison Lyleroehr, Leilani Lacson, et al.
American Journal of Clinical Oncology|June 18, 2015
c-Met Overexpression in Cervical Cancer, a Prognostic Factor and a Potential Molecular Therapeutic TargetTamer Refaat, Eric D Donnelly, Sean Sachdev, et al.
Cancers|May 11, 2024
The Evolving Classification of Meningiomas: Integration of Molecular Discoveries to Inform Patient CareS Joy Trybula, Mark W Youngblood, Constantine L Karras, et al.
Journal of Neuro-Oncology|March 20, 2019
NRG brain tumor specialists consensus guidelines for glioblastoma contouringTim J Kruser, Walter R Bosch, Shahed N Badiyan, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Neuro-Oncology Practice|February 7, 2025
Clinical outcomes for pleomorphic xanthoastrocytoma patientsJared J Sullivan, James P Chandler, Maciej S Lesniak, et al.
Journal of Neuro-Oncology|November 12, 2020
Long-term outcomes of spinal ependymomas: an institutional experience of more than 60 casesRohan Savoor, Timothy L Sita, Nader S Dahdaleh, et al.
CNS Oncology|May 23, 2023
HER2+ esophageal carcinoma leptomeningeal metastases treated with intrathecal trastuzumab regimenScott A Wu, Dan Tong Jia, Margaret Schwartz, et al.
Journal of Neuro-Oncology|June 12, 2024
Long-term outcomes of central neurocytoma - an institutional experienceYufan Yang, Nitin Wadhwani, Aoi Shimomura, et al.
World Neurosurgery|June 20, 2022
Mean Brain Dose Remains Uninfluenced by the Lesion Number for Gamma Knife Stereotactic Radiosurgery for 10+ MetastasesTimothy L Sita, Mahesh Gopalakrishnan, Michael K Rooney, et al.
Journal of Neuro-Oncology|October 24, 2021
A multi-center prospective study of re-irradiation with bevacizumab and temozolomide in patients with bevacizumab refractory recurrent high-grade gliomasKaran S Dixit, Sean Sachdev, Christina Amidei, et al.
BMC Cancer|April 25, 2024
A qualitative evaluation of factors influencing Tumor Treating fields (TTFields) therapy decision making among brain tumor patients and physiciansPriya Kumthekar, Madison Lyleroehr, Leilani Lacson, et al.
American Journal of Clinical Oncology|June 18, 2015
c-Met Overexpression in Cervical Cancer, a Prognostic Factor and a Potential Molecular Therapeutic TargetTamer Refaat, Eric D Donnelly, Sean Sachdev, et al.
Cancers|May 11, 2024
The Evolving Classification of Meningiomas: Integration of Molecular Discoveries to Inform Patient CareS Joy Trybula, Mark W Youngblood, Constantine L Karras, et al.
Journal of Neuro-Oncology|March 20, 2019
NRG brain tumor specialists consensus guidelines for glioblastoma contouringTim J Kruser, Walter R Bosch, Shahed N Badiyan, et al.
Pageof 7